Literature DB >> 25694134

Treatment of ocular motor palsies.

Imran Jivraj1, Vivek Patel.   

Abstract

OPINION STATEMENT: The management of ocular motor palsies first requires careful determination of the etiology. Possibilities include ischemia, inflammation, infection, trauma, compression, or congenital. Prognosis for recovery varies greatly between etiologies; hence, determination of the underlying process is crucial in the short- and long-term management of these patients. Naturally, our ultimate goal is to improve visual function as much as possible. A guiding principle in the initial management of ocular motor palsies is to improve patient comfort and visual function by eliminating diplopia in primary position while clinically observing the patient for improvement or stability. Offering a definitive treatment which creates the largest possible zone of binocular single vision in primary and reading positions can be undertaken once stability has been demonstrated. In the initial phase after an acute ocular motor palsy has occurred, occlusion of an eye can be used to eliminate diplopia. Options include a patch or applying translucent or satin tape to one of the lenses which prevents diplopia but still lets light through. Alternatively, prismatic correction placed on or ground into spectacles may improve function and restore binocularity in patients with temporary or permanent ocular deviations. This is generally effective for patients with up to 20 to 25 prism diopters (PD) of horizontal misalignment and 10 to 15 PD of vertical. Once a stable misalignment has been demonstrated (several months), a variety of surgical options exist. Use of adjustable sutures, improved suture materials, and surgical techniques has expanded the role and scope of surgery for these patients. Planning the surgical approach is based on residual extraocular muscle function, careful measurements, and assessment of patient expectations.

Entities:  

Year:  2015        PMID: 25694134     DOI: 10.1007/s11940-015-0338-5

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  38 in total

1.  Modified Harada-Ito procedure in bilateral superior oblique paresis.

Authors:  Clare Roberts; Emma Dawson; John Lee
Journal:  Strabismus       Date:  2002-09

2.  Effectiveness of prisms in the management of diplopia in patients due to diverse etiologies.

Authors:  Madhura A Tamhankar; Gui-shuang Ying; Nicholas J Volpe
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2012-02-28       Impact factor: 1.402

Review 3.  Management of paretic vertical deviations.

Authors:  Steven M Archer
Journal:  Am Orthopt J       Date:  2011

4.  Ability of an upright-supine test to differentiate skew deviation from other vertical strabismus causes.

Authors:  Agnes M F Wong; Linda Colpa; Manokaraananthan Chandrakumar
Journal:  Arch Ophthalmol       Date:  2011-12

5.  Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis.

Authors:  J M Holmes; R W Beck; K E Kip; P J Droste; D A Leske
Journal:  J AAPOS       Date:  2000-06       Impact factor: 1.220

Review 6.  Binocular vertical diplopia.

Authors:  P W Brazis; A G Lee
Journal:  Mayo Clin Proc       Date:  1998-01       Impact factor: 7.616

7.  The efficacy of vertical rectus transposition and its modalities in patients with abducens nerve palsy.

Authors:  Olimpia Nowakowska; Piotr Loba; Anna Broniarczyk-Loba
Journal:  Eur J Ophthalmol       Date:  2011 May-Jun       Impact factor: 2.597

8.  Simultaneous correction of blepharoptosis and exotropia in aberrant regeneration of the oculomotor nerve by strabismus surgery: a new, simplified ptosis correction for selected cases.

Authors:  F E O'Donnell; M Del Monte; D L Guyton
Journal:  Ophthalmic Surg       Date:  1980-10

9.  Retinal detachment from inadvertent intraocular injection of botulinum toxin A.

Authors:  Mimi Liu; Henry C Lee; Richard W Hertle; Allen C Ho
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

10.  Bilateral superior oblique palsy: etiology and therapeutic options.

Authors:  Pilar S Merino; Pilar L Rojas; Pilar S Gómez De Liaño; Hideki M Fukumitsu; Jacobo M Yáñez
Journal:  Eur J Ophthalmol       Date:  2013-09-05       Impact factor: 2.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.